Strategy (MSTR) Cash & Equivalents (2010 - 2026)

Strategy (MSTR) has 17 years of Cash & Equivalents data on file, last reported at $2.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 112513.21% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 112513.21% YoY), and the FY2025 full-year result was $2.3 billion, up 5937.91% from the prior year.
• Cash & Equivalents slipped to $2.2 billion in Q1 2026, from $2.3 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.3 billion in Q4 2025 to a low of $1.9 million in Q3 2024.
• A 5-year average of $313.0 million and a median of $60.4 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 97.59% in 2025 and jumped 112513.21% in 2026, its largest moves.
• Tracing MSTR's Cash & Equivalents over 5 years: stood at $43.8 million in 2022, then increased by 6.8% to $46.8 million in 2023, then declined by 18.58% to $38.1 million in 2024, then jumped by 5937.91% to $2.3 billion in 2025, then retreated by 4.1% to $2.2 billion in 2026.
• Business Quant data shows MSTR's Cash & Equivalents at $2.2 billion in Q1 2026, $2.3 billion in Q4 2025, and $54.3 million in Q3 2025.